Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher	pref label
tabling member	label

Search

1051490

	human indexable
	published
	registered interest
	answer date	04/02/2019
	date	30/01/2019
	date tabled	30/01/2019
	ddp created	30/01/2019 19:19:22
	answering body	Home Office
	question status	Tabled
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	ddp modified	01/02/2019 13:55:08 08/02/2019 12:42:02
	hansard heading	Overseas Loans: Mozambique
	house id	1
	identifier	214663
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	08/02/2019 12:10:23
	question text	To ask the Secretary of State for the Home Department, pursuant to the Answer of 28 January to Question 210062 on Loans: Mozambique, whether UK authorities plan to take action under the 2010 Bribery Act in relation to the allegations of K-based banks role in the $2 billion of loans to three state-owned companies in Mozambique.
	session	2017/19
	session number	1
	tabling member constituency	Liverpool, Walton
	tabling member printed	Dan Carden
	title	House of Commons Tabled Parliamentary Question 2017/19 214663
	type	WrittenParliamentaryQuestion
	uin	214663
	version	3
	written parliamentary question type	Ordinary
	answer	answer
	creator	4651 label Biography information for Dan Carden
	publisher	25259 pref label House of Commons
	tabling member	4651 label Biography information for Dan Carden

1051289

	human indexable
	published
	registered interest
	answer date	04/02/2019
	date	30/01/2019
	date tabled	30/01/2019
	ddp created	30/01/2019 19:09:56
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	30/01/2019 19:15:34 07/02/2019 14:19:02
	hansard heading	Kidney Cancer: Screening
	house id	1
	identifier	214526
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	07/02/2019 13:47:54
	question text	To ask the Secretary of State for Health and Social Care, if he will support the call by Kidney Cancer UK to fund research on a national screening programme for kidney cancer.
	session	2017/19
	session number	1
	tabling member constituency	Washington and Sunderland West
	tabling member printed	Mrs Sharon Hodgson
	title	House of Commons Tabled Parliamentary Question 2017/19 214526
	type	WrittenParliamentaryQuestion
	uin	214526
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1521 label Biography information for Mrs Sharon Hodgson
	publisher	25259 pref label House of Commons
	tabling member	1521 label Biography information for Mrs Sharon Hodgson

1051292

	human indexable
	published
	registered interest
	answer date	04/02/2019
	date	30/01/2019
	date tabled	30/01/2019
	ddp created	30/01/2019 19:10:07
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	30/01/2019 19:15:46 07/02/2019 15:49:02
	hansard heading	Air Pollution
	house id	1
	identifier	214452
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	07/02/2019 15:17:23
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 16 January 2019 to Question 206215 on Air Pollution, what the implications for his policies are of the statement in the Public Health England report, published in March 2017, entitled Air Quality A Briefing for Directors of Public Health that PM is inhaled into the lungs and ultrafine PM0.1 is thought to pass into the blood causing many adverse outcomes including systemic inflammation.
	session	2017/19
	session number	1
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	title	House of Commons Tabled Parliamentary Question 2017/19 214452
	type	WrittenParliamentaryQuestion
	uin	214452
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	252 label Biography information for Dr David Drew
	publisher	25259 pref label House of Commons
	tabling member	252 label Biography information for Dr David Drew

1051336

	human indexable
	published
	registered interest
	answer date	04/02/2019
	date	30/01/2019
	date tabled	30/01/2019
	ddp created	30/01/2019 19:11:58
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	30/01/2019 19:18:00 07/02/2019 15:55:32
	hansard heading	Autoimmune Diseases
	house id	1
	identifier	214623
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	07/02/2019 15:23:09
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the annual cost to the public purse of treating and managing (a) rheumatoid arthritis, (b) inflammatory bowel disease and (c) psoriasis.
	session	2017/19
	session number	1
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	title	House of Commons Tabled Parliamentary Question 2017/19 214623
	type	WrittenParliamentaryQuestion
	uin	214623
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4532 label Biography information for Derek Thomas
	publisher	25259 pref label House of Commons
	tabling member	4532 label Biography information for Derek Thomas

1051338

	human indexable
	published
	registered interest
	answer date	04/02/2019
	date	30/01/2019
	date tabled	30/01/2019
	ddp created	30/01/2019 19:12:03
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	30/01/2019 19:18:06 07/02/2019 15:53:02
	hansard heading	Autoimmune Diseases
	house id	1
	identifier	214625
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	07/02/2019 15:21:20
	question text	To ask the Secretary of State for Health and Social Care, whether (a) his Department and (b) NHS England have made a comparative assessment of the effectiveness of treating immune-mediated inflammatory conditions (i) holistically and (ii) according to the physical location of the inflammation; and if he will make a statement.
	session	2017/19
	session number	1
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	title	House of Commons Tabled Parliamentary Question 2017/19 214625
	type	WrittenParliamentaryQuestion
	uin	214625
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4532 label Biography information for Derek Thomas
	publisher	25259 pref label House of Commons
	tabling member	4532 label Biography information for Derek Thomas

1051440

	human indexable
	published
	registered interest
	answer date	04/02/2019
	date	30/01/2019
	date tabled	30/01/2019
	ddp created	30/01/2019 19:16:45
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	30/01/2019 19:26:26 07/02/2019 15:54:02
	hansard heading	Kawasaki Disease
	house id	1
	identifier	214517
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	07/02/2019 15:22:23
	question text	To ask the Secretary of State for Health and Social Care, what recent steps he is taking to raise awareness of the signs and symptoms of Kawasaki disease among NHS health professionals.
	session	2017/19
	session number	1
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	title	House of Commons Tabled Parliamentary Question 2017/19 214517
	type	WrittenParliamentaryQuestion
	uin	214517
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1400 label Biography information for Kevin Brennan
	publisher	25259 pref label House of Commons
	tabling member	1400 label Biography information for Kevin Brennan

1051478

	human indexable
	published
	registered interest
	answer date	04/02/2019
	date	30/01/2019
	date tabled	30/01/2019
	ddp created	30/01/2019 19:18:41
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	30/01/2019 19:27:53 07/02/2019 14:27:02
	hansard heading	Diabetes: Medical Equipment
	house id	1
	identifier	214470
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	07/02/2019 13:55:36
	question text	To ask the Secretary of State for Health and Social Care, how many Abbott FreeStyle Libre flash glucose monitoring devices and sensors local clinical commissioning groups prescribed in (a) 2017-18 (b) 2018-19 to date.
	session	2017/19
	session number	1
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	title	House of Commons Tabled Parliamentary Question 2017/19 214470
	type	WrittenParliamentaryQuestion
	uin	214470
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	338 label Biography information for Keith Vaz
	publisher	25259 pref label House of Commons
	tabling member	338 label Biography information for Keith Vaz

1051483

	human indexable
	published
	registered interest
	answer date	04/02/2019
	date	30/01/2019
	date tabled	30/01/2019
	ddp created	30/01/2019 19:19:01
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	30/01/2019 19:28:09 08/02/2019 13:04:01
	hansard heading	Diabetes: Medical Equipment
	house id	1
	identifier	214472
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	08/02/2019 12:32:42
	question text	To ask the Secretary of State for Health and Social Care, what is the cost to the NHS is of each FreeStyle Libre flash glucose monitoring device.
	session	2017/19
	session number	1
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	title	House of Commons Tabled Parliamentary Question 2017/19 214472
	type	WrittenParliamentaryQuestion
	uin	214472
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	338 label Biography information for Keith Vaz
	publisher	25259 pref label House of Commons
	tabling member	338 label Biography information for Keith Vaz

1051485

	human indexable
	published
	registered interest
	answer date	04/02/2019
	date	30/01/2019
	date tabled	30/01/2019
	ddp created	30/01/2019 19:19:06
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	31/01/2019 15:05:30 07/02/2019 15:50:02
	hansard heading	Diabetes: Medical Equipment
	house id	1
	identifier	214473
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	07/02/2019 15:18:43
	question text	To ask the Secretary of State for Health and Social Care, what representations his Department has made to the pharmaceutical company Abbott on the availability of FreeStyle Libre being issued to people with Type 1 diabetes from April 2019.
	session	2017/19
	session number	1
	tabling member constituency	Leicester East
	tabling member printed	Keith Vaz
	title	House of Commons Tabled Parliamentary Question 2017/19 214473
	type	WrittenParliamentaryQuestion
	uin	214473
	version	2
	written parliamentary question type	Ordinary
	answer	answer
	creator	338 label Biography information for Keith Vaz
	publisher	25259 pref label House of Commons
	tabling member	338 label Biography information for Keith Vaz

1051337

	human indexable
	published
	registered interest
	answer date	04/02/2019
	date	30/01/2019
	date tabled	30/01/2019
	ddp created	30/01/2019 19:12:00
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	30/01/2019 19:18:03 08/02/2019 13:20:05
	hansard heading	Out-patients
	house id	1
	identifier	214624
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	08/02/2019 12:48:04
	question text	To ask the Secretary of State for Health and Social Care, when his Department plans to launch its review of outpatient services; and if his Department will include in that review services for (a) rheumatoid arthritis, (b) inflammatory bowel disease, (c) psoriasis and (d) other immune-mediated inflammatory conditions.
	session	2017/19
	session number	1
	tabling member constituency	St Ives
	tabling member printed	Derek Thomas
	title	House of Commons Tabled Parliamentary Question 2017/19 214624
	type	WrittenParliamentaryQuestion
	uin	214624
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4532 label Biography information for Derek Thomas
	publisher	25259 pref label House of Commons
	tabling member	4532 label Biography information for Derek Thomas